近期论文
查看导师最新文章
（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）
Zhenqi Jiang (#), Yinjie Wang (#), Li Sun, Bo Yuan, Yuchen Tian, Lingchao Xiang, Yanying Li, Yong Li, Juan Li (*), Aiguo Wu (*), Dual ATP and pH responsive ZIF-90 nanosystem with favorable biocompatibility and facile post-modification improves therapeutic outcomes of triple negative breast cancer in vivo, Biomaterials, 2019, 197: 41-50.
Zhenqi Jiang(#), Yuchen Tian(#), Dingying Shan, Yinjie Wang, Ethan Gerhard, Jianbi Xia, Rong Huang, Yan He, Aiguo Li, Jianchao Tang, Huimin Ruan, Yong Li, Jian Yang, Juan Li (*), Aiguo Wu (*), pH protective Y1 receptor ligand functionalized antiphagocytosis BPLP-WPU micelles for enhanced tumor imaging and therapy with prolonged survival time, Biomaterials, 2018, 170: 70-81
Juan Li (#), Yuchen Tian (#), Dingying Shan, An Gong, Leyong Zeng, Wenzhi Ren, Lingchao Xiang, Jinshun Zhao, Jian Yang, Aiguo Wu (*)，Neuropeptide Y Y1 receptor-mediated biodegradable photoluminescent nanobubbles as ultrasound contrast agents for targeted breast cancer imaging, Biomaterials, 2017, 116: 106-117
Zhenqi Jiang (#), Bo Yuan (#), Nianxiang Qiu, Yinjie Wang, Li Sun, Zhenni Wei, Yanyin Li, Jianjun Zheng, Yinhua Jin, Yong Li, Shiyu Du, Juan Li (*), Aiguo Wu (*). Manganese-Zeolitic Imidazolate Frameworks-90 with High Blood Circulation Stability for MRI-Guided Tumor Therapy. Nano-Micro Letters, 2019, 11, 61.
Yinjie Wang (#), Zhenqi Jiang (#), Bo Yuan, YuchenTian, Lingchao Xiang, Yanying Li, Yong Yang, Juan Li (*), Aiguo Wu (*), Y1 receptor ligand synergized with P-glycoprotein inhibitor improves therapeutic efficacy of multidrug resistant breast cancer，Biomaterials Science, 2019, DOI: 10.1039/C9BM00337A.
Zhangsen Yu, Yuanzhi Xia, Jie Xing, Zihou Li, Jianjun Zhen, Yinhua Jin, Yuchen Tian, Chuang Liu, Zhenqi Jiang, Juan Li (*), Aiguo Wu (*), Y1-receptor–ligand-functionalized ultrasmall upconversion nanoparticles for tumor targeted trimodality imaging and photodynamic therapy with low toxicity, Nanoscale, 2018, 10: 17038-17052 (Featured in Outside Back Cover)
Juan Li (#), Yang Du (#), Zhenqi Jiang, Yuchen Tian, Nianxiang Qiu, Yinjie Wang, Muhammad Zubair lqbal, Menying Hu, Ruifen Zou, Lijia Luo, Shiyu Du, Jie Tian (*), Aiguo Wu (*), Y1 receptor ligand-based nanomicelle as a novel nanoprobe for glioma-targeted imaging and therapy, Nanoscale, 2018,10: 5845-5851
Juan Li, Zheyu Shen，Xuehua Ma，Wenzhi Ren，Lingchao Xiang，An Gong，Tian Xia， Junming Guo, Aiguo Wu (*)，Neuropeptide Y Y-1 Receptors meditate targeted delivery of anticancer drug with encapsulated nanoparticles to breast cancer cells with high selectivity and its potential for breast cancer therapy, ACS Applied Materials & Interfaces, 2015, 7: 5574-5582
Juan Li (*), Yuchen Tian, Aiguo Wu (*)，Neuropeptide Y receptors: a promising target for cancer imaging and therapy, Regenerative Biomaterials, 2015, 2: 215-219
Hong Su, Xin Song, Juan Li, Muhammad Zubair Iqbal, Samuel Selorm Fiati Kenston, Zhen Li, Aiguo Wu, Min Ding, Jinshun Zhao (*), Biosafety evaluation of Janus Fe3O4-TiO2 nanoparticles in Sprague Dawley rats after intravenous injection, International Journal of Nanomedicine, 2018, 13: 6987-7001
Hong Su, Zhou Li, Lissy Lazar, Yasmin Alhamoud, Xin Song, Juan Li, Yafei Wang, Samuel Selorm Fiati kenston, Muhammad Zubair Lqbal, Aiguo Wu, Zhen Li, Qihang Hua, Min Ding, Jinshun Zhao, In vitro evaluation of the toxicity and underlying molecular mechanisms of Janus Fe3O4-TiO2 nanoparticles in human liver cells, Environmental Toxicology, 2018, 33: 1078-1088.
Xiaoxia Wu, Yuanzhi Xia, Youju Huang, Juan Li, Huimin Ruan, Liqiang Luo, Sugeun Yang, Zheyu Shen*, Aiguo Wu*. Improved SERS nanoparticles with various shape for direct detection of circulating tumor cells in the blood with supersensitivity and high specificity. ACS Applied Materials & Interfaces, 2016, 8: 19928-19938
Juan Li，Zheyu Shen，Xuehua Ma，Wenzhi Ren，Lingchao Xiang，An Gong，Tian Xia， Junming Guo，Aiguo Wu(*), Neuropeptide Y Y1 receptors mediate targeted delivery nanoparticles for breast cancer therapy, Neuropeptides, 2016, 55: 7-8
京公网安备 11010802027423号